TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
Home > ÀüÁ¦Ç°º¸±â > NGS °ü·Ã > DNA-seq °³¿ä > [Cancer Research] Cancer Genomics & Epigenomics

[Cancer Research] Cancer Genomics & Epigenomics

-



Bringing epigenomic profiling to the single-cell biology stage

°£È¤ ¿¬±¸ÀÚµéÀº ±â¹ßÇÏ°í Çõ½ÅÀûÀÎ ¿¬±¸¸¦ ½ÇÇàÇÒ ¹æ¹ýÀ» ã±â Èûµé ¶§°¡ ÀÖ´Ù. ÀÌó·³ ÀÌÀü¿¡´Â ºÒ°¡´ÉÇß´ø »õ·Î¿î ¿¬±¸ºÐ¾ß¸¦ À§Çؼ­´Â À̸¦ Àû¿ëÇÒ ¼ö ÀÖ´Â µµ±¸°¡ µÞ¹ÞħµÇ¾î¾ß ÇÑ´Ù.
ICELL8¢ç Single-Cell SystemÀº ÀÌ·¯ÇÑ »óȲ¿¡µµ Àû¿ëÇÒ ¼ö ÀÖµµ·Ï open platformÀ¸·Î ¼³°èµÇ¾úÀ¸¸ç, ½ÇÁ¦·Î ¸¹Àº ¿¬±¸ÀÚµéÀÌ À̸¦ È°¿ëÇÏ°í ÀÖ´Ù. Fred Hutchinson Cancer Research ¼Ò¼ÓÀÇ Steven Henikoff ¹Ú»ç ¿¬±¸±×·ìÀ» ¿¹·Î µé¾îº¼ ¼ö ÀÖÀ¸¸ç, CUT&Tag (Cleavage Under Targets and Tagmentation)À» ÀÌ¿ëÇÑ »õ·Î¿î Èļº À¯ÀüÇÐ ¿¬±¸ ±â¹ýÀ» °³¹ßÇÏ¿© single cell¿¡¼­ ³ôÀº ¼öÁØÀÇ chromatin mappingÀ» °¡´ÉÄÉ Çß´Ù (Kaya-Okur et al. 2019).

Going beyond ChIP-seq

Èļº À¯ÀüÇÐÀº µ¿ÀÏÇÑ Genotype¿¡¼­ DNA ±¸Á¶¿Í È÷½ºÅæÀÇ º¯Çü, DNA methylationÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â À¯ÀüÀÚ ¹ßÇö°ú Ç¥ÇöÇü º¯È­¸¦ ÀÌÇØÇÏ´Â Çй®ÀÌ´Ù (Deichmann 2016). ÀÌ·¯ÇÑ Èļº À¯ÀüÇÐÀû ºÐ¼®À» À§ÇØ ChIP-seqÀÌ ¸¹Àº ¿ªÇÒÀ» ÇßÀ¸³ª, ºÐ¼®À» À§ÇÑ »ùÇà ¾çÀÌ ÃæºÐÇÏÁö ¾Ê°Å³ª ³ôÀº ¹é±×¶ó¿îµå·Î ÀÎÇØ ºÐ¼® °á°ú°¡ ÁÁÁö ¾Ê´Â µîÀÇ ÇÑ°è°¡ ÀÖ¾ú´Ù.
ÀûÀº ¼öÀÇ ¼¼Æ÷¸¦ ºÐ¼®Çϱâ À§ÇØ ³·Àº ¹é±×¶ó¿îµå¸¦ °¡Áö´Â ½ÇÇè ¹æ¹ýÀ» °³¹ßÇÏ´Â °ÍÀº ¸Å¿ì Áß¿äÇß´Ù. 2017³â Skene ¹Ú»ç¿Í Henikoff ¹Ú»ç´Â Transcription-factor-DNA (TF-DNA) complexÀÇ Æ¯Á¤ DNA ´ÜÆí ¾ç ¸»´Ü¿¡ Á¸ÀçÇϸ鼭 Ç×ü¿Í °áÇÕÇϴ Ư¡À» ÀÌ¿ëÇÏ¿©, protein A-monococcal nuclease (protein A-MNase)¿Í °áÇÕ½ÃÄÑ ChIP-seqÀÇ ÇÑ°èÁ¡À» ±Øº¹ÇÏ´Â CUT&RUNÀ» °³¹ßÇس´Ù.

Getting to the single-cell level

CUT&RUN ¹æ¹ýÀº ÀÚµ¿È­°¡ °¡´ÉÇÏ°í, ÀûÀº »ùÇà ¾çÀ¸·Îµµ ºÐ¼®ÀÌ °¡´ÉÇÔ¿¡µµ ºÒ±¸ÇÏ°í, Dr. Henikoff ¹Ú»ç¿Í ¿¬±¸±×·ìÀº À̸¦ Á» ´õ °³¼±ÇÏ°íÀÚ Çß´Ù. ƯÈ÷ TF-DNA complex¸¦ ÀÌ¿ëÇØ library¸¦ Á¦ÀÛÇÒ ¶§, DNA ¸»´Ü Á¦°Å¿Í adapter ligation ´Ü°è¸¦ »ý·«ÇÏ°íÀÚ Çß´Ù. º» ¿¬±¸ ±×·ìÀº ±âÁ¸ÀÇ Mnase°¡ °áÇÕµÈ protein A¸¦ hyperactive Tn5 transposase (pA-Tn5)°¡ °áÇÕµÈ protein A·Î ´ëüÇÏ¿© CUT&Tag ¹æ¹ýÀ» °³¹ßÇÏ¿´´Ù. pA-Tn5°¡ È°¼ºÈ­ µÇ°Ô µÇ¸é, »çÀü¿¡ ·ÎµùµÈ sequencing adapter°¡ TF-DNA ¾ç ¸»´Ü°ú ºÎÂøµÊÀ¸·Î½á PCR ÁõÆøÀ» À§ÇÑ »ê¹°ÀÌ »ý¼ºµÇ¸ç, ChIP-seq ½ÇÇè°ú ºñ±³ÇßÀ» ¶§ ºÐ¼® ¹üÀ§°¡ 20¹è °¡·® Çâ»óµÇ¾ú´Ù.


±×¸² 1. ICELL8 Single-Cell SystemÀ» ÀÌ¿ëÇÑ CUT&Tag °úÁ¤
(Panel A) Schematic depicting the CUT&Tag process. The target protein (blue) is bound by the primary antibody (green), which is then bound by a secondary antibody (orange). An adapter (red)-loaded Tn5 transposase conjugated to protein A (grey) then binds the secondary antibody, tethering it and promoting the incorporation of adapters at the target site. Fragments are then enriched by PCR.
(Panel B) Workflow of single-cell CUT&Tag as performed on our ICELL8 Single-Cell System. (Figure by Kaya-Okur et al. 2019, used under CC-BY-NC-ND 4.0)

Kaya-Okur et al. ³í¹®¿¡¼­´Â CUT&Tag ¹æ¹ýÀÌ single cell¿¡µµ Àû¿ë °¡´ÉÇÑÁö¸¦ È®ÀÎÇÏ¿´´Ù (scCUT&Tag). ÇØ´ç ÇÁ·ÎÅäÄÝÀº ¼¼Æ÷ÀÇ Permeabilization °úÁ¤ÀÌ ¿ä±¸µÇ±â¿¡, ¼Õ»óµÇ±â ½¬¿î ¼¼Æ÷¸¦ single cell·Î ºÐ¸®ÇÒ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ÇÊ¿ä·Î Çß´Ù. ´ÙÄ«¶ó¹ÙÀÌ¿ÀÀÇ ICELL8 ÀÚµ¿È­ Ç÷§ÆûÀ» ÀÌ¿ëÇϸé ÀÌ permeabilizedµÈ ¼¼Æ÷¸¦ 5,184°³ÀÇ wellÀ» °¡Áö´Â chip¿¡ ºÐÁÖÇÏ°í tagmentationÀ» ÁøÇàÇÒ ¼ö ÀÖ´Ù. °Ô´Ù°¡, ½Ã½ºÅÛÀÇ À̹ÌÁö ÅëÇÕ ±â´ÉÀ» ÅëÇØ Well ³»ÀÇ ¼¼Æ÷¸¦ ½Ã°¢ÀûÀ¸·Î È®ÀÎÇÒ ¼ö ÀÖ¾î, ÇϳªÀÇ ¼¼Æ÷¸¸À» °¡Áö´Â well¿¡ ½Ã¾àÀ» ¼±ÅÃÀûÀ¸·Î Àû¿ëÇÏ¿© PCR enrichment °úÁ¤À» ÁøÇàÇÒ ¼ö ÀÖ´Ù. ÀÌÈÄ ¿¬±¸ÀÚµéÀº ICELL8¢ç SystemÀÇ ½ºÅ©¸³Æ®¸¦ ÀÌ¿ëÇؼ­ °¢ 72°³ÀÇ i5¿Í i7 index¸¦ ºÐÁÖÇÏ¿© °¢°¢ÀÇ ¼¼Æ÷°¡ °íÀ¯ÇÑ index¸¦ °®µµ·Ï ÇÑ ÈÄ, À̸¦ ÃßÀû ºÐ¼®ÇÏ¿´´Ù. º» ³í¹®ÀÇ ÀúÀÚµéÀº ÀÌ °úÁ¤¿¡¼­ scCUT&Tag ¹æ¹ýÀ» ÀÌ¿ëÇÑ ½ÇÇè °á°ú°¡ chromatin profiling °á°ú¿Í Àß ÀÏÄ¡ÇÔÀ» È®ÀÎÇÏ¿´´Ù (³í¹® ³» ±×¸² 6).

Code

Á¦Ç°¸í

¿ë·®

640189

ICELL8¢ç cx Single-Cell System

1 System



[¿ø¹®] Bringing epigenomic profiling to the single-cell biology stage
[Âü°í¹®Çå]
- Deichmann, U. Epigenetics: The origins and evolution of a fashionable topic. Dev. Biol. 416, 249-254 (2016).
- Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. bioRxiv 568915 (2019).
- Skene, P. J. & Henikoff, S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife 6, (2017).